Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

Data as of 3:59pm ET
 +0.01 / +0.48%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line-5.7M-10.7M-6.0M-13.3M
Total Other Cash Flow-4.4M2.4M-6.4M2.6M
Funds From Operations-9.3M-7.5M-11.5M-9.9M
Funds From/For Other Operating Expenses1.3M3.6M1.9M-103.0K
Net Cash Flow - Operating Activities-10.7M-11.2M-13.5M-9.8M
InvestingNet Cash Flow Investing-231.0K8.4M-35.4M9.7M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing4.4M38.5M6.3M1.2M
Exchange RateEffect of Exchange Rate on Cash0.
Net Change In Cash-6.5M35.8M-42.6M1.1M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.